Merck & Co., Inc. (NYSE:MRK)
Morgan Stanley Healthcare Conference
September 12, 2017, 02:50 PM ET
Executives
Ken Frazier - Chief Executive Officer
Roger Perlmutter - Executive Vice President and President, Merck Research Laboratories
Analysts
David Risinger - Morgan Stanley
David Risinger
All right. Busy times for Merck, so we're getting started a few minutes late, but we very much appreciate the Merck management team being here today. So, I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures.
It's my pleasure to welcome Ken Frazier and Roger Perlmutter. Ken serves as the President and CEO. He originally joined Merck in 1992 as General Counsel and Secretary of the Astra-Merck joint venture. Took on positions of increasing responsibility and was named CEO of Merck in 2011.
Roger has served as Executive Vice President and President of Merck Research Labs since 2013. He rejoined Merck after serving as Head of R&D at Amgen from 2001 to 2012. And thanks again both for joining us today.
I thought it would be great, Ken, to just start out with actually you talk about your vision for Merck and how you want to develop the company going forward.
